Safety of Elacestrant in ER+/HER2- and ESR1 Mutations MBC

NCT06544577 · clinicaltrials.gov ↗

RECRUITING

Status

350

Enrollment

INDUSTRY

Sponsor class

Conditions

ESR1 Gene Mutation
Advanced Breast Cancer
Safety

Interventions

DRUG: ELacestrant

Sponsor

SciClone Pharmaceuticals